EHP Funds Inc’s Organon & Co OGN Stock Holding History

EHP Funds Inc’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,100	Closed	-$290K	–	191
2023 Q4	$290K	Buy	+20,100	New	+$273K	0.11%	116

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EHP Funds Inc's OGN Position: Q1 2024 in Review

EHP Funds Inc sold out of Organon & Co (OGN) in Q1 2024, closing a stake of 20,100 shares — an estimated $290K sold.

EHP Funds Inc first reported a position in OGN in Q4 2023 and held it in 1 quarter. The position peaked at $290K in Q4 2023. 721 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

EHP Funds Inc reported no remaining Organon & Co position as of Q1 2024 after selling out during the quarter.
EHP Funds Inc sold 20,100 Organon & Co shares in Q1 2024, an estimated $290K.
EHP Funds Inc first reported a position in Organon & Co in Q4 2023 and held it in 1 quarter.
EHP Funds Inc's Organon & Co position peaked at $290K in Q4 2023.
721 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on EHP Funds Inc's 13F filing for Q1 2024, filed 15 May 2024.